These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 16284097)
1. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Theander E; Henriksson G; Ljungberg O; Mandl T; Manthorpe R; Jacobsson LT Ann Rheum Dis; 2006 Jun; 65(6):796-803. PubMed ID: 16284097 [TBL] [Abstract][Full Text] [Related]
2. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Theander E; Manthorpe R; Jacobsson LT Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310 [TBL] [Abstract][Full Text] [Related]
3. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome. Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245 [TBL] [Abstract][Full Text] [Related]
5. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Kauppi M; Pukkala E; Isomäki H Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244 [TBL] [Abstract][Full Text] [Related]
6. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome. Brito-Zerón P; Kostov B; Fraile G; Caravia-Durán D; Maure B; Rascón FJ; Zamora M; Casanovas A; Lopez-Dupla M; Ripoll M; Pinilla B; Fonseca E; Akasbi M; de la Red G; Duarte-Millán MA; Fanlo P; Guisado-Vasco P; Pérez-Alvarez R; Chamorro AJ; Morcillo C; Jiménez-Heredia I; Sánchez-Berná I; López-Guillermo A; Ramos-Casals M; J Hematol Oncol; 2017 Apr; 10(1):90. PubMed ID: 28416003 [TBL] [Abstract][Full Text] [Related]
7. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Ioannidis JP; Vassiliou VA; Moutsopoulos HM Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410 [TBL] [Abstract][Full Text] [Related]
8. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis. Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972 [TBL] [Abstract][Full Text] [Related]
9. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome. Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010 [TBL] [Abstract][Full Text] [Related]
11. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687 [TBL] [Abstract][Full Text] [Related]
12. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome. Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392 [TBL] [Abstract][Full Text] [Related]
13. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases]. Jia N; Tang FL Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605 [TBL] [Abstract][Full Text] [Related]
14. Risk of malignancy in Korean patients with primary Sjögren's syndrome. Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507 [TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma]. Li YQ; Yu QM; Li J; Yang JR; Niu T Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260 [TBL] [Abstract][Full Text] [Related]
17. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645 [TBL] [Abstract][Full Text] [Related]
18. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study. Baldini C; Santini E; Rossi C; Donati V; Solini A J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820 [TBL] [Abstract][Full Text] [Related]
19. Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study. Rocca J; Beydon M; Le Guern V; Hachulla E; Couderc M; Jousse-Joulin S; Devauchelle-Pensec V; Gottenberg JE; Vittecoq O; Lavigne C; Schmidt J; Larroche C; Mariette X; Seror R; Nocturne G Lancet Rheumatol; 2024 Oct; 6(10):e703-e712. PubMed ID: 39182508 [TBL] [Abstract][Full Text] [Related]
20. The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies. Ansari N; Salesi M Clin Rheumatol; 2024 Jul; 43(7):2177-2186. PubMed ID: 38722505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]